Enliang Li
- Oncology top 10%
- Molecular Biology
- Immunology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Topics
- Pancreatic and Hepatic Oncology Research (8 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers)Gallbladder and Bile Duct Disorders (7 papers)
- Cited by
- OncologyCancer ResearchHepatology
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Enliang Li
47 papers receiving 786 citations
Peers
Comparison fields: 5 of 77
- Oncology 353
- Molecular Biology 275
- Immunology 187
- Cancer Research 179
- Pulmonary and Respiratory Medicine 153
Countries citing papers authored by Enliang Li
This map shows the geographic impact of Enliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enliang Li more than expected).
Fields of papers citing papers by Enliang Li
This network shows the impact of papers produced by Enliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enliang Li. The network helps show where Enliang Li may publish in the future.
Co-authorship network of co-authors of Enliang Li
This figure shows the co-authorship network connecting the top 25 collaborators of Enliang Li. A scholar is included among the top collaborators of Enliang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enliang Li. Enliang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 11 | |
| 10 | 11 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 4 | |
| 14 | 10 | |
| 15 | 166 | |
| 16 | 56 | |
| 17 | 30 | |
| 18 | 30 | |
| 19 | 47 | |
| 20 | 11 |
About Enliang Li
Enliang Li is a scholar working on Hepatology, Oncology and Cancer Research, having authored 52 papers that have together received 801 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Gallbladder and Bile Duct Disorders (7 papers). The work is most often cited by research in Oncology (353 citations), Cancer Research (179 citations) and Hepatology (84 citations). Enliang Li has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Tingbo Liang, Xing Huang, Gang Zhang, Xiaozhen Zhang, Tianyu Tang, Xueli Bai, Xun Wang, Yingmin Wang, Linquan Wu and Wenjun Liao. Their work appears in journals such as Nature Communications, Scientific Reports and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.